Status: Recruiting
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Participants needed: 200
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: VesalioUpdated: May 27, 2026Locations: 16Duration: 30 Days
Eligibility criteria
Age ≥22 [+3]
None